A share repurchase of $1 billion would reduce the share count by 24.1 million or a 3.8% reduction in the number of shares outstanding. So, the $62.86 price target would become $65.34.

United Therapeutics (NASDAQ:UTHR) has entered into two accelerated share repurchase deal to buy back an aggregate of $1 billion of its common stock. The company will repurchase these shares as part of ...

--Aterian, Inc., a technology-enabled consumer products company, announced today that its Board of Directors has authorized a share repurchase program of up to $3.0 million of the Company’ s ...

This authorization supplements the Board’s previous share repurchase plan approved in May 2023, which authorized the repurchase of up to $250 million of SkyWest’s common stock, of which ...

Coeur Mining, Inc. today announced that its Board of Directors has authorized a $75 million share repurchase program, effective through May 31, 2026. "We are pleased to announce this share ...

PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today announced that its Board of Directors authorized a new share repurchase program of $600 million of its common shares on ...

Under terms of the agreement, Collegium will pay $25 million to Jefferies LLC and will receive an initial delivery of 692,281 shares, based on the $28.89 closing stock price of Collegium’s ...

STAAR Surgical Announces $30 Million Share Repurchase Authorization STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...